NFE2L2 and melanoma: As mutant NRF2 was previously described to enhance the expression of EGFR ligands Tgfa, Areg, and Egf in a mouse model for hepatomegaly [34], we considered the possibility that endogenous wild type NRF2 might have a similar effect in human melanoma.